1. Home
  2. Research
  3. Research Groups
  4. Molecular Pathology of Cancer Group

Molecular Pathology of Cancer Group

Search for publications

Only original articles, editorials, guidelines.

  • Vaz Batista M, Pérez-García JM, Garrigós L, García-Sáenz JÁ, Cortez P, Racca F, Blanch S, Ruiz-Borrego M, Fernández-Ortega A, Fernández-Abad M, Iranzo V, Gion M, Martrat G, Alcalá-López D, Pérez-Escuredo J, Sampayo-Cordero M, Llombart-Cussac A, Braga S, Cortés J.

    The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with carcinomatosis

    MED . 6(1): 100502-100502. Number of citations: 28

    [doi:10.1016/j.medj.2024.08.001]

  • Niedra H, Rogoza O, Saksis R, Peculis R, Halilova A, Gerina A, Vilisova S, Senterjakova N, Pukitis A, Ruz-Caracuel I, Earl J, Kolnikova G, Dubovan P, Tomas M, Makovicky P, Urbanova M, Smolkova B, Koniaris E, Aggelioudaki I, Kataki A, Rovite V.

    Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers

    Plos One . 20(6): .

    [doi:10.1371/journal.pone.0325672]

  • Ruiz-Cánovas JM, Achote-Rea EA, Alonso-Gordoa T, Martínez-Lorca A, Araujo-Castro M.

    Metastatic pheochromocytoma: An unusual case and its multidisciplinary management

    Hipertension y riesgo vascular . 42(1): 59-62.

    [doi:10.1016/j.hipert.2024.09.002]

  • González-Martín A, Rubio MJ, Heitz F, Depont Christensen R, Colombo N, Van Gorp T, Romeo M, Ray-Coquard I, Gaba L, Leary A, De Sande LM, Lebreton C, Redondo A, Fabbro M, Barretina Ginesta MP, Follana P, Pérez-Fidalgo JA, Rodrigues M, Santaballa A, Sabatier R, Bermejo-Pérez MJ, Lotz JP, Pardo B, Marquina G, Sánchez-Lorenzo L, Quindós M, Estévez-García P, Guerra Alía E, Manso L, Casado V, Kommoss S, Tognon G, Henry S, Bruchim I, Oaknin A, Selle F.

    Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

    JOURNAL OF CLINICAL ONCOLOGY . 42(36): 4294-4304.

    [doi:10.1200/JCO.24.00668]

  • Ruz-Caracuel I, Pedraza-Arevalo S, Alonso-Gordoa T, Molina-Cerrillo J, Earl J, Sainz B Jr.

    Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask.

    Endocrine Oncology (bristol, England) . 4(1): .

    [doi:10.1530/EO-24-0006]

  • Grazioso TP, Del Mar Rigual M, Perna C, Caleiras EJ, Djouder N.

    Cold exposure reinstates NAD(+) levels and attenuates hepatocellular carcinoma.

    Cell Stress . 8: 125-139.

    [doi:10.15698/cst2024.12.302]

  • Bonura GF, Biancheri P, Rainer J, Soriani P, Rodriguez de Santiago E, Parrella A, Campioli A, Guerra E, Gualdi E, Pignatti A, Manno M.

    Spinal anesthesia for endoscopic submucosal dissection of large rectosigmoid lesions: Feasibility study.

    Endoscopy International Open . 12(12): 1447-1452.

    [doi:10.1055/a-2441-2543]

  • Montégut C, Falandry C, Cinieri S, Cropet C, Montane L, Rousseau F, Joly F, Moubarak M, Mosconi AM, Guerra-Alía EM, Schauer C, Fujiwara H, Vergote I, Parma G, Lindahl G, Anota A, Canzler U, Marmé F, Pujade-Lauraine E, Ray-Coquard I, Sabatier R.

    Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA-1/ENGOT-ov25.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae322]

  • Mata-Castro N, Castañeda-Vozmediano R, Perna C, Prada Puentes C, Sanz López L.

    Histological Findings of Resected Tracheal Ring in SARS-CoV-2-Positive and -Negative Tracheostomized Patients.

    LIFE-BASEL . 14(12): .

    [doi:10.3390/life14121655]

  • Garcia-Donas, Jesus, Garrigos, Laia, Lainez, Nuria, Santaballa, Ana, Redondo, Andres, Cueva, Juan Fernando, Rubio, M. Jesus, Prieto, Mario, Lopez-Guerrero, Jose Antonio, Garcia-Casado, Zaida, Barquin, Aranzanzu, Grande, Enrique, Alia, Eva Guerra, Sevillano, Elena, Bover, Isabel, Grazioso, Tatiana P., Sanchez-Escribano, Ramon, Hurtado, Alicia, Navarro, Paloma, Rodriguez-Moreno, Juan Francisco.

    Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01)

    CLINICAL & TRANSLATIONAL ONCOLOGY . 27(7): 3223-3231.

    [doi:10.1007/s12094-024-03827-4]

  • Cortés A, López-Miranda E, Fernández-Ortega A, Carañana V, Servitja S, Urruticoechea A, Lema-Roso L, Márquez A, Lazaris A, Alcalá-López D, Mina L, Gener P, Rodríguez-Morató J, Antonarelli G, Llombart-Cussac A, Pérez-García J, Cortés J.

    Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study.

    Breast . 78: 103834-103834.

    [doi:10.1016/j.breast.2024.103834]

  • Matias-Guiu X, Lax S, Raspollini MR, Palacios J, Zheng W, Liu C, de Brot L, Lordello L, Hardisson D, Gaffney D, Mutch D, Scambia G, Creutzberg CL, Fotopoulou C, Berek JS, Concin N.

    FIGO 2023 staging for endometrial cancer, when, if it is not now?

    EUROPEAN JOURNAL OF CANCER . 213: 115115-115115.

    [doi:10.1016/j.ejca.2024.115115]

  • Cortés-Salgado A, Serrano JJ, Cordero Pereda D, Menacho M, del Rey JM, Del Campo-Albendea L, Saavedra C, Chamorro J, Rosero D, Sotoca P, Guillén-Ponce C, Guerra E, Fernández-Abad M, López-Miranda E, Martínez-Jáñez N, Gion M, Salazar MT, Agudo-Quílez P, Garrido P, Alonso Salinas GL.

    Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae299]

  • Quintela-Fandino M, Bermejo B, Zamora E, Moreno F, Garcia-Saenz JÁ, Pernas S, Martinez Jañez N, Jiménez D, Adrover E, Andrés R, Mourón S, Bueno MJ, Manso L, Viñas G, Alba E, Llombart-Cussac A, Cortes J, Tebar C, Roe DJ, Grant A, Watson A, Colomer R, Mouneimne G.

    High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer.

    CLINICAL CANCER RESEARCH . 30(22): 5094-5104.

    [doi:10.1158/1078-0432.CCR-24-1518]

  • Verlingue L, Italiano A, Prenen H, Guerra Alia EM, Tosi D, Perets R, Lugowska I, Moiseyenko V, Gumus M, Arslan C, Lindsay CR, Deva S, Taus Á, Oaknin A, Rottey S, Cicin I, Goksu SS, Smolin A, Roselló-Keränen S, Habigt C, Marbach D, Boetsch C, Dejardin D, Sleiman N, Evers S, Richard M, Ardeshir C, Charo J, Kraxner A, Teichgräber V, Keshelava N, Dziadziuszko R.

    Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

    EBioMedicine . 109: 105374-105374. Number of citations: 1

    [doi:10.1016/j.ebiom.2024.105374]

  • Perez-Fidalgo JA, Gálvez-Montosa F, Guerra EM, Madariaga A, Manzano A, Martin-Lorente C, Rubio-Pérez MJ, Alarcón J, Barretina-Ginesta MP, Gaba L.

    SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023).

    CLINICAL & TRANSLATIONAL ONCOLOGY . 26(11): 2758-2770. Number of citations: 2

    [doi:10.1007/s12094-024-03531-3]

  • Alonso-Gordoa T, Jimenez-Fonseca P, Martinez-Trufero J, Navarro M, Porras I, Rubió-Casadevall J, Arregui Valles M, Basté N, Hernando J, Iglesias Docampo L.

    SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).

    CLINICAL & TRANSLATIONAL ONCOLOGY . 26(11): 2902-2916.

    [doi:10.1007/s12094-024-03736-6]

  • Carretero-Barrio I, Pijuan L, Illarramendi A, Curto D, López-Ríos F, Estébanez-Gallo Á, Castellvi J, Granados-Aparici S, Compañ-Quilis D, Noguera R, Esteban-Rodríguez I, Sánchez-Güerri I, Ramos-Guerra AD, Ortuño JE, Garrido P, Ledesma-Carbayo MJ, Benito A, Palacios J.

    Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology.

    SCIENTIFIC REPORTS . 14(1): 24163-24163.

    [doi:10.1038/s41598-024-75175-w]